{
  "slug": "telomere-shortening",
  "case_path": "hsef_v53_remaining_priority_06_10_2026-10-09\\telomere-shortening",
  "round": 2,
  "group": 1,
  "review_date": "2026-10-14",
  "adversarial_reviewer": "Claude Opus 5.5 (Anthropic)",
  "authoring_model_of_record": "Sol 6.1",
  "authoring_model_as_declared_in_package": "Codex; HSEF v5.3 (house provenance per the lead; left unedited)",
  "status": "Approved as revised",
  "level_before": "Γ",
  "level_after": "Γ",
  "descriptor_after": "Mechanistically plausible, partial system support",
  "confidence_before": "Moderate",
  "confidence_after": "Moderate",
  "confidence_rationale_corrected": true,
  "role_before": "reinforcing / stabilizing factor",
  "role_after": "reinforcing / stabilizing factor",
  "subclaims_before": {
    "SC1": "Ε",
    "SC2": "Ε",
    "SC3": "Γ"
  },
  "subclaims_after": {
    "SC1": "Ε",
    "SC2": "Ε",
    "SC3": "Γ"
  },
  "aggregation_rule": "primary-subclaim (SC3)",
  "aggregation_alternatives": {
    "weakest_link": "Γ",
    "primary_subclaim": "Γ",
    "scope_matched": "Γ"
  },
  "msd_before": {
    "momentum": "Mechanistic only",
    "stability": "Stable",
    "divergence": "Contested"
  },
  "msd_after": {
    "momentum": "Mechanistic only",
    "stability": "Stable",
    "divergence": "Contested"
  },
  "sources_total_before": 51,
  "sources_total_after": 51,
  "claims_total": 55,
  "pmids_checked": 54,
  "pmids_reference_list": 51,
  "pmids_prose_only": 3,
  "pmids_failed": 0,
  "retractions_or_eocs_found": 0,
  "claims_spot_checked": 12,
  "claims_spot_check_failures": 0,
  "validator": {
    "tool": "framework/hsef-hypothesis-review-v5/tools/validate_review.py",
    "before": "PASS - 0 fail, 0 warn, 31 pass",
    "after": "PASS - 0 fail, 0 warn, 31 pass",
    "output_file": "validator.txt"
  },
  "findings_by_severity": {
    "critical": 0,
    "major": 2,
    "minor": 2,
    "editorial": 0
  },
  "findings": [
    {
      "id": "E-1",
      "severity": "Minor",
      "category": "rendering defect / internal inconsistency",
      "location": "document-wide",
      "original": "59 occurrences of PMID fused to its digits",
      "corrected": "PMID <digits>",
      "evidence": "The whitespace-loss defect class named in the round-2 brief. The reference list already used the spaced form 61 times in the same document.",
      "artifacts_changed": [
        "telomere-shortening.review.md"
      ]
    },
    {
      "id": "E-2",
      "severity": "Major",
      "category": "false provenance claim",
      "location": "Registered claim and scope - Selection sentence",
      "original": "Registered claim assessed against original sources; existing HIV draft consulted after a source-based checkpoint. This is not independent blinded calibration.",
      "corrected": "Registered claim assessed against original sources. This is not independent blinded calibration.",
      "evidence": "No HIV draft belongs to this case's provenance. The clause is batch boilerplate: it appears identically in all five case files of hsef_v53_remaining_priority_06_10_2026-10-09 and is accurate only for hiv-aids. A provenance sentence naming a consultation that did not happen misrepresents how the review was produced, hence Major rather than Editorial.",
      "lead_flagged": true,
      "precedent": "Another group applied the same correction to dopamine-schizophrenia.",
      "artifacts_changed": [
        "telomere-shortening.review.md"
      ]
    },
    {
      "id": "E-3",
      "severity": "Major",
      "category": "confidence band justified by reviewer access depth",
      "location": "telomere-shortening.scorecard.json, final_score.confidence_rationale",
      "original": "51 primary reports with 6 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness.",
      "corrected": "Moderate reflects evidence density and reproducibility, not correctness and not this reviewer's access depth. The cellular and model-organism evidence replicates well, but the evidence bearing on the registered ordinary-human claim rests on small intervention cohorts, uncontrolled syndrome treatment and mean-leukocyte-telomere-length instruments, and the functional and lifespan results are discordant. Access depth is recorded separately in the provenance header and is not a basis for the band.",
      "evidence": "The framework states that confidence reflects evidence density and reproducibility, and that access depth is 'a statement about what you did, not about the source'. The original rationale made this reviewer's incomplete access one of three stated grounds for the band, which is not a permitted input.",
      "band_changed": false,
      "band_argued_both_ways": "Moderate stands. The High text requires extensive independent replication across labs, models and assay modalities with reproducibility well established. That is met only at SC1/SC2 scope. At the registered SC3 scope the evidence is a single mouse gene-therapy programme, one pharmacological activator, an uncontrolled syndrome treatment, one randomized supplement trial with a telomere-length endpoint, and mean-LTL Mendelian-randomization instruments whose functional and lifespan results are discordant.",
      "lead_flagged": true,
      "artifacts_changed": [
        "telomere-shortening.scorecard.json"
      ]
    },
    {
      "id": "E-4",
      "severity": "Minor",
      "category": "missing required artifact (Divergence)",
      "location": "Final score, causal direction and M/S/D - Divergence line",
      "original": "Divergence: Contested. No manufactured field consensus or arithmetic gap. These dimensions do not change level or confidence.",
      "corrected": "Same verdict with the split named: the telomerase gene-therapy, TERT-activator and telomere-hallmark literature presents attrition as a modifiable driver of organismal aging, while the Mendelian-randomization and large-cohort literature in this same evidence base reports null lifespan and functional-aging effects alongside an opposing cancer risk and presents leukocyte telomere length as a marker.",
      "evidence": "The framework requires a checkable artifact for Divergence and permits 'Contested' only where the field is genuinely split. The original sentence asserted the verdict and declined the artifact, which is the defaulting the v4.0 re-anchoring exists to expose. The added clause uses only framings already documented in this review's own evidence base.",
      "artifacts_changed": [
        "telomere-shortening.review.md"
      ]
    }
  ],
  "rejected_findings": [
    {
      "id": "R-1",
      "checked": "References printing a year one off the PubMed publication-date year",
      "disposition": "Rejected per the round-2 print-versus-e-pub convention."
    },
    {
      "id": "R-2",
      "checked": "Headline Gamma drawn from a subclaim set whose two other members are Epsilon",
      "disposition": "Rejected - the brief's warned pattern, handled correctly. The pre-registered rule is primary-subclaim and SC3 is the registered claim verbatim; SC1 (cellular dysfunction) and SC2 (inherited disorders and experimental models) are explicitly scope-restricted and cannot set a headline about ordinary human aging. Scope-matched returns Gamma for the same reason, weakest-link also returns Gamma since Gamma is the lowest letter in the set, and all three are reported."
    },
    {
      "id": "R-3",
      "checked": "Collective-author builder defect (leading comma, dropped consortium author)",
      "disposition": "Rejected - checked and CORRECTLY HANDLED here, which is worth recording because the upstream cause is present. Reference 11 is the Telomeres Mendelian Randomization Collaboration paper (PMID 28241208), whose PubMed record carries a CollectiveName and whose first author object the PubMed tool returns EMPTY - exactly what produces the ', Haycock PC ...' defect elsewhere. This review renders it correctly as 'Telomeres Mendelian Randomization Collaboration, Haycock PC, Burgess S et al.'"
    },
    {
      "id": "R-4",
      "checked": "Renderer bug: 'Best-supported rival' printing models_evaluated[0], often the nominal",
      "disposition": "Rejected - checked and not present. models_evaluated[0] is 'Context-dependent telomere pathology' with rank_in_tournament 1 and is_nominal false, while the nominal 'Telomere primacy' is at index 3, rank 4. The prose names the rank-1 non-nominal model, which is correct. Lead-flagged corpus-wide."
    },
    {
      "id": "R-5",
      "checked": "Momentum 'Mechanistic only'",
      "disposition": "Rejected. Artifact named and checkable: the TERT-activator compound study (PMID 38908367, 2024) is active mechanistic work improving functional tests in aged mice that explicitly calls for experiments separating canonical from noncanonical TERT actions, while the examined TA-65 and danazol programmes do not test ordinary-human healthspan primacy. Nothing in the examined evidence addresses the boundary check, which is what the value means."
    },
    {
      "id": "R-6",
      "checked": "Stability 'Stable'",
      "disposition": "Rejected. The framework states that where no trigger can be named the answer is Stable by definition; the review says no verified named pending result was identified and explicitly declines to claim that no relevant trial exists."
    },
    {
      "id": "R-7",
      "checked": "Role 'reinforcing / stabilizing factor' rather than 'primary driver'",
      "disposition": "Rejected. The derivation runs the ordered procedure, records that steps 3 and 4 fail at ordinary-human scope, and stops at step 5."
    },
    {
      "id": "R-8",
      "checked": "Errata for references 1, 3 and 23 absent from the numbered list",
      "disposition": "Rejected - correct ledger discipline. Corrections attach to the parent row's status flags and never take a numbered row; giving them rows would inflate sources_total from 51 to 54."
    }
  ],
  "residual_limitations": [
    "45 of 51 records are at bounded abstract and status depth. Three weight-bearing details could not be reached at abstract depth and rest on the review's own partial-body reading: the gene-therapy group sizes of 14-23 animals in a predominantly C57BL/6 background (PMID 22585399), the sex and normal-aging-control detail attributed to the endogenous-reactivation experiment (PMID 21113150), and the participant loss during TA-65 follow-up (PMID 26950204). All three are consistent with their abstracts; none is flagged as an error.",
    "The rubric fit is an acknowledged adaptation: rubric 06 governs functional aging claims and rubric 02 supplies the TERT oncogenic trade-off, and the review interprets cellular SC1 through tissue function rather than cell doublings. The adaptation is stated and bounded, but the SC1 threshold reasoning rests on it.",
    "The strongest positive broad-aging evidence is a single mouse gene-therapy programme and one pharmacological activator, both in one species. Gamma should not be read as a refutation of telomere biology."
  ],
  "scorecard_changed": true,
  "scorecard_change_detail": "One line only: final_score.confidence_rationale (finding E-3). No level, band, count or role moved. CRLF line endings preserved, so the diff against sol61-original is exactly one line.",
  "package_level_propagation": {
    "strings_to_replace": [
      {
        "what": "telomere-shortening.review.md sha256 in this case folder's SHA256.txt and any package MANIFEST/BATCH_COMPLETION entry carrying it",
        "old": "d832ae6505a01b4e85f4e7ab063fba38604743959e52a1289f4ba8b8eafb492f",
        "new": "264aacbcdd3a89d1b7d59949eac3a4fdafa6ad492369deeefb02235bb9700c0c"
      },
      {
        "what": "telomere-shortening.scorecard.json sha256 in this case folder's SHA256.txt and any package MANIFEST/BATCH_COMPLETION entry carrying it",
        "old": "e1644e0d0e6ac18155bc217d052b11568feb68c55d557f5ff6944e40bb31261f",
        "new": "612ee431ed6d91f54776b8647f70d9c7fb6ec82d807ba5640c4cc4d1750bd61c"
      }
    ],
    "batch_wide_action": "Lead-flagged artifacts confirmed batch-wide: the false HIV-draft provenance clause and the access-depth confidence rationale appear across hsef_v53_remaining_priority_06_10_2026-10-09, and the PMID<digits> fusion is in all five case files (dopamine-schizophrenia 73, hiv-aids 52, inflammation-depression 74, lipid-heart-diet 55, telomere-shortening 59). hiv-aids is the one case where the HIV clause may be accurate and should be checked rather than stripped.",
    "note": "No headline string, letter, confidence band, count or title changed, so OVERVIEW.md-class values are not stale."
  },
  "changed_file_hashes": {
    "telomere-shortening.review.md": {
      "sha256": "5cf320e0b8f56553c3343a753cb8235c21b515ca7b31897f68861db92db9e292",
      "bytes": 89927,
      "previous_sha256": "d832ae6505a01b4e85f4e7ab063fba38604743959e52a1289f4ba8b8eafb492f"
    },
    "telomere-shortening.scorecard.json": {
      "sha256": "612ee431ed6d91f54776b8647f70d9c7fb6ec82d807ba5640c4cc4d1750bd61c",
      "bytes": 252439,
      "previous_sha256": "e1644e0d0e6ac18155bc217d052b11568feb68c55d557f5ff6944e40bb31261f"
    },
    "validator.txt": {
      "sha256": "35a311b6a7c1c3b2817ffe96153898f98cec950b2e9e13488b0eb5fb8497c9a7",
      "bytes": 2343,
      "new_file": true
    },
    "ADVERSARIAL_REVIEW.md": {
      "sha256": "d0576ebd5cd7d4e6341913eb93fd064fc56c4acd0d2fb85d766af52a7d6c10a7",
      "bytes": 8086,
      "new_file": true
    }
  },
  "propagate_to": [],
  "divergent_copies": [],
  "consensus_questions": [
    "In adults without an inherited telomere biology disorder, does any intervention that measurably lengthens or maintains telomeres improve a prespecified functional healthspan endpoint - not telomere length itself - in a randomized trial?",
    "Does Mendelian randomization support a causal effect of genetically predicted telomere length on human lifespan?"
  ],
  "lead_policy_2026_10_14": {
    "confidence_two_step_test": {
      "step1_strike_access_depth": "applied; access-depth clause removed from the rationale (finding E-3)",
      "step2_rederive_band": "Moderate stands",
      "surviving_valid_determinants": [
        "evidence at the registered scope is a single mouse gene-therapy programme with groups of 14-23 animals, one pharmacological activator, an uncontrolled syndrome treatment whose primary endpoint was telomere attrition rather than function, and one randomized supplement trial measuring telomere length rather than healthspan",
        "mean-leukocyte-telomere-length Mendelian-randomization instruments give discordant functional and lifespan results",
        "mean leukocyte telomere length is a reporter rather than a tissue-specific critical-telomere readout, a determinant the policy names as valid",
        "the cellular and model-organism evidence does replicate well, but that replication sits at SC1/SC2 scope, not at the registered scope that sets the band"
      ],
      "band_before": "Moderate",
      "band_after": "Moderate",
      "band_changed": false
    },
    "momentum_stricter_rule": {
      "value": "Mechanistic only",
      "result": "holds; positive contrast",
      "basis": "Already the conservative value, and its artifact is a COMPLETED 2024 publication (PMID 38908367) - which under the stricter rule is precisely why it cannot support 'Decisive work underway'. The review does not claim otherwise: it calls the study active mechanistic work and states that the examined TA-65 and danazol programmes do not test ordinary-human healthspan primacy.",
      "completed_work_counted_as_momentum": false
    },
    "policy_as_stated_by_lead": "Confidence: strike access depth as a determinant everywhere, then re-derive; raise the band only if access depth was the only thing holding it down and the cited evidence meets the High text. Documented evidence-quality or reproducibility concerns are valid determinants and the band stands. Momentum: 'Decisive work underway' requires work actually being run that could cross the next threshold; a completed publication or trial never satisfies it."
  }
}